Bibliografías temáticas / Aldosteronism / Artículos de revistas
Siga este enlace para ver otros tipos de publicaciones sobre el tema: Aldosteronism.

Artículos de revistas sobre el tema "Aldosteronism"

Autor: Grafiati
Publicado: 11 de marzo de 2023

Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros

Elija tipo de fuente:

Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Aldosteronism".

Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.

También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.

Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.

1

Freel, Ellen Marie. "Primary Aldosteronism or Not Primary Aldosteronism". Hypertension 69, n.º 5 (mayo de 2017): 780–81. http://dx.doi.org/10.1161/hypertensionaha.117.09050.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

Funder, John W. "Primary Aldosteronism". Hypertension 77, n.º 3 (3 de marzo de 2021): 900–903. http://dx.doi.org/10.1161/hypertensionaha.120.16585.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Subbarao, Kakarla. "Primary Aldosteronism". Hypertension Journal 2, n.º 3 (2016): 178–79. http://dx.doi.org/10.5005/jp-journals-10043-0051.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

Wrenn, Sean M., Anand Vaidya y Carrie C. Lubitz. "Primary aldosteronism". Gland Surgery 9, n.º 1 (febrero de 2020): 14–24. http://dx.doi.org/10.21037/gs.2019.10.23.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

Bravo, Emmanuel L. "Primary Aldosteronism". Urologic Clinics of North America 16, n.º 3 (agosto de 1989): 481–86. http://dx.doi.org/10.1016/s0094-0143(21)01830-9.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

Ghannam, Nadia. "Primary Aldosteronism". Annals of Saudi Medicine 5, n.º 1 (enero de 1985): 51–53. http://dx.doi.org/10.5144/0256-4947.1985.51.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

HELLEM, ARVID J. "Primary Aldosteronism". Acta Medica Scandinavica 155, n.º 4 (24 de abril de 2009): 271–74. http://dx.doi.org/10.1111/j.0954-6820.1956.tb14374.x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

Pillai, Padma Raghavan, Mindy Griffith, Monica D. Schwarcz y Irene A. Weiss. "Primary Aldosteronism". Cardiology in Review 28, n.º 2 (2020): 84–91. http://dx.doi.org/10.1097/crd.0000000000000281.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

Lo, Chung Yau, Po Chor Tam, Annie W. C. Kung, Karen S. L. Lam y John Wong. "Primary Aldosteronism". Annals of Surgery 224, n.º 2 (agosto de 1996): 125–30. http://dx.doi.org/10.1097/00000658-199608000-00003.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

YOUNG, WILLIAM F. "Primary Aldosteronism". Cardiology in Review 7, n.º 4 (julio de 1999): 207–14. http://dx.doi.org/10.1097/00045415-199907000-00012.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
11

Stowasser, Michael, Richard D. Gordon, Terry J. Tunny, Shelley A. Klemm, Wendy L. Finn y Anton L. Krek. "Primary aldosteronism". Journal of Hypertension 9, n.º 6 (diciembre de 1991): S266. http://dx.doi.org/10.1097/00004872-199112000-00116.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
12

Stowasser, Michael, Richard D. Gordon, Terry J. Tunny, Shelley A. Klemm, Wendy L. Finn y Anton L. Krek. "Primary aldosteronism". Journal of Hypertension 9 (1991): S266. http://dx.doi.org/10.1097/00004872-199112006-00116.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
13

Byrd, James Brian, Adina F. Turcu y Richard J. Auchus. "Primary Aldosteronism". Circulation 138, n.º 8 (21 de agosto de 2018): 823–35. http://dx.doi.org/10.1161/circulationaha.118.033597.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
14

YOUNG, WILLIAM F. "Primary Aldosteronism". Annals of the New York Academy of Sciences 970, n.º 1 (septiembre de 2002): 61–76. http://dx.doi.org/10.1111/j.1749-6632.2002.tb04413.x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
15

Ganguly, Arunabha. "Primary Aldosteronism". New England Journal of Medicine 339, n.º 25 (17 de diciembre de 1998): 1828–34. http://dx.doi.org/10.1056/nejm199812173392507.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
16

Gomez-Sanchez, Celso E. "Primary Aldosteronism". Hypertension 63, n.º 4 (abril de 2014): 668–69. http://dx.doi.org/10.1161/hypertensionaha.113.02335.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
17

Funder, John W. "Primary Aldosteronism". Hypertension 74, n.º 3 (septiembre de 2019): 458–66. http://dx.doi.org/10.1161/hypertensionaha.119.12935.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
18

Yang, Yuhong, Celso E. Gomez-Sanchez, Diana Jaquin, Elke Tatjana Aristizabal Prada, Lucie S. Meyer, Thomas Knösel, Holger Schneider, Felix Beuschlein, Martin Reincke y Tracy Ann Williams. "Primary Aldosteronism". Hypertension 74, n.º 4 (octubre de 2019): 809–16. http://dx.doi.org/10.1161/hypertensionaha.119.13476.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
19

Funder, John W. "Primary Aldosteronism". Hypertension 76, n.º 2 (agosto de 2020): 325–26. http://dx.doi.org/10.1161/hypertensionaha.120.15456.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
20

Stowasser, Michael y Richard D. Gordon. "Primary aldosteronism". Best Practice & Research Clinical Endocrinology & Metabolism 17, n.º 4 (diciembre de 2003): 591–605. http://dx.doi.org/10.1016/s1521-690x(03)00050-2.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
21

Corry, Dalila B. y Michael L. Tuck. "Secondary Aldosteronism". Endocrinology and Metabolism Clinics of North America 24, n.º 3 (septiembre de 1995): 511–30. http://dx.doi.org/10.1016/s0889-8529(18)30029-x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
22

Litchfield, W. Reid y Robert G. Dluhy. "Primary Aldosteronism". Endocrinology and Metabolism Clinics of North America 24, n.º 3 (septiembre de 1995): 593–612. http://dx.doi.org/10.1016/s0889-8529(18)30033-1.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
23

Young, William F. y George G. Klee. "Primary Aldosteronism". Endocrinology and Metabolism Clinics of North America 17, n.º 2 (junio de 1988): 367–95. http://dx.doi.org/10.1016/s0889-8529(18)30425-0.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
24

Travers, S., A. Blanchard, E. Cornu, C. Faucard, L. Baffalie, M. Azizi, P. Houillier, L. Amar y S. Baron. "PRIMARY ALDOSTERONISM". Journal of Hypertension 37 (julio de 2019): e30. http://dx.doi.org/10.1097/01.hjh.0000570660.50840.c1.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
25

Pego, M., J. Maldonado, B. Ponces, F. Alves, P. Almeida, F. J. Oliveira y E. Castro Sousa. "PRIMARY ALDOSTERONISM". Journal of Hypertension 18 (junio de 2000): S34. http://dx.doi.org/10.1097/00004872-200006001-00103.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
26

Stowasser, Michael y Richard D. Gordon. "Primary aldosteronism". Journal of Hypertension 18, n.º 9 (septiembre de 2000): 1165–76. http://dx.doi.org/10.1097/00004872-200018090-00002.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
27

Stewart, Paul y William Young. "Primary Aldosteronism". Journal of Clinical Endocrinology & Metabolism 92, n.º 12 (1 de diciembre de 2007): E1. http://dx.doi.org/10.1210/jcem.92.12.9996.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
28

Ansari, Azam. "Primary aldosteronism". Lancet 360, n.º 9333 (agosto de 2002): 617. http://dx.doi.org/10.1016/s0140-6736(02)09785-4.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
29

Bravo, Emmanuel L. "Primary Aldosteronism". Cardiology Clinics 6, n.º 4 (noviembre de 1988): 509–15. http://dx.doi.org/10.1016/s0733-8651(18)30473-9.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
30

Galati, Sandi-Jo. "Primary Aldosteronism". Endocrinology and Metabolism Clinics of North America 44, n.º 2 (junio de 2015): 355–69. http://dx.doi.org/10.1016/j.ecl.2015.02.010.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
31

Rossi, Gian Paolo. "Primary Aldosteronism". Journal of the American College of Cardiology 74, n.º 22 (diciembre de 2019): 2799–811. http://dx.doi.org/10.1016/j.jacc.2019.09.057.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
32

Shuto, Yujin. "Primary Aldosteronism". Journal of Nippon Medical School 68, n.º 5 (2001): 447–49. http://dx.doi.org/10.1272/jnms.68.447.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
33

Wu, Vin-Cent, Chin-Chi Kuo, Shuo-Meng Wang, Kao-Lang Liu, Kuo-How Huang, Yen-Hung Lin, Tzong-Shinn Chu et al. "Primary aldosteronism". Journal of Hypertension 29, n.º 9 (septiembre de 2011): 1778–86. http://dx.doi.org/10.1097/hjh.0b013e3283495cbb.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
34

Kaplan, Norman M. "Primary aldosteronism". Journal of Hypertension 30, n.º 10 (octubre de 2012): 1899–902. http://dx.doi.org/10.1097/hjh.0b013e3283559a03.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
35

LINS, PER-ERIC y ULF ADAMSON. "Primary Aldosteronism". Acta Medica Scandinavica 221, n.º 3 (24 de abril de 2009): 275–82. http://dx.doi.org/10.1111/j.0954-6820.1987.tb00894.x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
36

Kim, Sang Wan. "Primary Aldosteronism". Korean Journal of Medicine 82, n.º 4 (2012): 396. http://dx.doi.org/10.3904/kjm.2012.82.4.396.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
37

Carey, Robert M. "Primary Aldosteronism". Hormone Research in Paediatrics 71, n.º 1 (2009): 8–12. http://dx.doi.org/10.1159/000178029.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
38

Bergman, B. O. "Primary aldosteronism". Urology 35, n.º 5 (mayo de 1990): 393–98. http://dx.doi.org/10.1016/0090-4295(90)80079-3.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
39

Gordon, R. D. "Primary aldosteronism". Journal of Endocrinological Investigation 18, n.º 7 (julio de 1995): 495–511. http://dx.doi.org/10.1007/bf03349761.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
40

Pitt, Bertram y James Brian Byrd. "Primary Aldosteronism". JACC: Cardiovascular Imaging 13, n.º 10 (octubre de 2020): 2160–61. http://dx.doi.org/10.1016/j.jcmg.2020.06.025.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
41

Satoh, Fumitoshi, Ryo Morimoto, Yoshitsugu Iwakura, Yoshikiyo Ono, Masataka Kudo, Kei Takase y Sadayoshi Ito. "Primary aldosteronism". Reviews in Endocrine and Metabolic Disorders 12, n.º 1 (9 de febrero de 2011): 11–14. http://dx.doi.org/10.1007/s11154-011-9161-9.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
42

Gröndal, S. y B. Hamberger. "Primary aldosteronism". British Journal of Surgery 79, n.º 6 (junio de 1992): 484–85. http://dx.doi.org/10.1002/bjs.1800790604.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
43

Auchus, Richard J. y Fiemu E. Nwariaku. "Primary aldosteronism". Current Cardiology Reports 9, n.º 6 (noviembre de 2007): 447–52. http://dx.doi.org/10.1007/bf02938388.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
44

Carey, Robert M. "Primary aldosteronism". Journal of Surgical Oncology 106, n.º 5 (17 de julio de 2012): 575–79. http://dx.doi.org/10.1002/jso.23206.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
45

Moraitis, Andreas y Constantine Stratakis. "Adrenocortical Causes of Hypertension". International Journal of Hypertension 2011 (2011): 1–10. http://dx.doi.org/10.4061/2011/624691.

Texto completo
Resumen
Primary aldosteronism is the most common cause of secondary hypertension. In the past, screening for primary aldosteronism was offered only in patients with hypertension associated with hypokalemia. Recent studies showed that hypokalemia is seen in only 25% of the patients with primary aldosteronism, which has increased the prevalence of primary aldosteronism to 10–15% of all cases with new onset hypertension.
Los estilos APA, Harvard, Vancouver, ISO, etc.
46

Hundemer, Gregory L. y Anand Vaidya. "MANAGEMENT OF ENDOCRINE DISEASE: The role of surgical adrenalectomy in primary aldosteronism". European Journal of Endocrinology 183, n.º 6 (diciembre de 2020): R185—R196. http://dx.doi.org/10.1530/eje-20-0863.

Texto completo
Resumen
Primary aldosteronism is common and contributes to adverse cardiovascular, kidney, and metabolic outcomes. When instituted early and effectively, targeted therapies can mitigate these adverse outcomes. Surgical adrenalectomy is among the most effective treatments because it has the potential to cure, or attenuate the severity of, pathologic aldosterone excess, resulting in a host of biochemical and clinical changes that improve health outcomes. Herein, we review the role of surgical adrenalectomy in primary aldosteronism while emphasizing the physiologic ramifications of surgical intervention, and compare these to other targeted medical therapies for primary aldosteronism. We specifically review the role of curative adrenalectomy for unilateral primary aldosteronism, the role of non-curative adrenalectomy for bilateral primary aldosteronism, and how these interventions influence biochemical and clinical outcomes in relation to medical therapies for primary aldosteronism.
Los estilos APA, Harvard, Vancouver, ISO, etc.
47

Gomez-Sanchez, Celso E. "Guía para el manejo del Aldosteronismo Primario". Diagnóstico 61, n.º 1 (14 de marzo de 2022): e350. http://dx.doi.org/10.33734/diagnostico.v61i1.350.

Texto completo
Resumen
El aldosteronismo primario es la causa de hipertensión secundaria más común que afecta entre 5-24% de los pacientes con hipertensión arterial y está asociada a un incremento de la morbilidad cardiovascular, cerebrovascular y renal comparada con pacientes con hipertensión primaria. El diagnóstico depende de la demostración de una elevación autónoma de la secreción de aldosterona con respecto a un aumento de la ingesta de sal y que no responde al sistema renina-angiotensina. Las causas más comunes del aldosteronism primario son debidos a un adenoma adrenal productor de aldosterona, hiperplasia bilateral idiopática y menos comunes son la hiperplasia unilateral idiopática y el carcinoma adrenal causante de aldosteronismo. El diagnóstico diferencial es realizado usando una tomografía adrenal y especialmente con el muestreo de las venas adrenales. El tratamiento de adenomas es por una adrenalectomíalaparoscópica y en el caso del aldosteronismo bilateral idiopático tratamiento médico con bloqueadores del receptor mineralocorticoide (espirolactonas o eplerenona).
Los estilos APA, Harvard, Vancouver, ISO, etc.
48

Schirpenbach, Caroline, Lysann Seiler, Christiane Maser-Gluth, Frank Rüdiger, Christian Nickel, Felix Beuschlein y Martin Reincke. "Confirmatory testing in normokalaemic primary aldosteronism: the value of the saline infusion test and urinary aldosterone metabolites". European Journal of Endocrinology 154, n.º 6 (junio de 2006): 865–73. http://dx.doi.org/10.1530/eje.1.02164.

Texto completo
Resumen
Objective: Primary aldosteronism has recently been recognized as the most frequent cause of secondary hypertension. Since most patients are normokalaemic, differentiation to essential hypertension is challenging. As differentiation by baseline aldosterone/renin ratio may be insufficient, diagnosis should be confirmed by additional tests. However, as most confirmatory tests have been evaluated in hypokalaemic primary aldosteronism only, we reassessed the value of the saline infusion test and 24 h urinary aldosterone metabolites as confirmatory tests for both normo- and hypokalaemic primary aldosteronism under current antihypertensive medication. Patients and methods: 25 patients with primary aldosteronism (11 hypokalaemic, 14 normokalaemic), 29 patients with essential hypertension and 47 normotensive subjects were studied. The hypertensives received their usual medication with the exception of spironolactone. All subjects underwent a standard saline infusion test (determination of plasma aldosterone before and after 2.0 liters of isotonic saline for 4 hours i.v.) and collected a 24 h urine sample for examination of urinary tetrahydroaldosterone and aldosterone-18-glucuronide. Results: In hypokalaemic primary aldosteronism the saline infusion test showed a reasonable sensitivity (91%) and specificity (90%). However, the test failed to differentiate sufficiently between essential hypertension and normokalaemic primary aldosteronism (sensitivity 57%, specificity 90%). Similarly, urinary tetrahydroaldosterone had higher sensitivity in hypokalaemic than in normokalaemic primary aldosteronism (sensitivity 64% vs 36%, specificity 100%), whereas for aldosterone-18-glucuronide, no differences in hypo- and normokalaemic primary aldosteronism were found (sensitivity 45% and 43%, specificity 100%). Conclusions: These data show that the saline infusion test as an established test in classical hypokalaemic primary aldosteronism is not a reliable test in the normokalaemic variant of the disease. Due to its low accuracy, determination of urinary aldosterone metabolites did not prove useful in confirming either normo- or hypokalaemic patients. We conclude from our data that these tests should not be used as confirmatory testing in the normokalaemic variant of primary aldosteronism.
Los estilos APA, Harvard, Vancouver, ISO, etc.
49

Vaidya, Anand y Robert M. Carey. "Evolution of the Primary Aldosteronism Syndrome: Updating the Approach". Journal of Clinical Endocrinology & Metabolism 105, n.º 12 (31 de agosto de 2020): 3771–83. http://dx.doi.org/10.1210/clinem/dgaa606.

Texto completo
Resumen
Abstract Context New approaches are needed to address the evolution of the primary aldosteronism syndrome and to increase its recognition. Herein, we review evidence indicating that primary aldosteronism is a prevalent syndrome that is mostly unrecognized, and present a pragmatic and pathophysiology-based approach to improve diagnosis and treatment. Methods Evidence was gathered from published guidelines and studies identified from PubMed by searching for primary aldosteronism, aldosterone, renin, and hypertension. This evidence was supplemented by the authors’ personal knowledge, research experience, and clinical encounters in primary aldosteronism. Interpretation of Evidence Renin-independent aldosterone production is a prevalent phenotype that is diagnosed as primary aldosteronism when severe in magnitude, but is largely unrecognized when milder in severity. Renin-independent aldosterone production can be detected in normotensive and hypertensive individuals, and the magnitude of this biochemical phenotype parallels the magnitude of blood pressure elevation, the risk for incident hypertension and cardiovascular disease, and the likelihood and magnitude of blood pressure reduction with mineralocorticoid receptor antagonist therapy. Expansion of the indications to screen for primary aldosteronism, combined with the use of a pathophysiology-based approach that emphasizes inappropriate aldosterone production in the context of renin suppression, will substantially increase the diagnostic and therapeutic yields for primary aldosteronism. Conclusions The landscape of primary aldosteronism has evolved to recognize that it is a prevalent syndrome of renin-independent aldosterone production that contributes to the pathogenesis of hypertension and cardiovascular disease. Expanding screening indications and simplifying the diagnostic approach will enable implementation of targeted treatment for primary aldosteronism.
Los estilos APA, Harvard, Vancouver, ISO, etc.
50

Stavropoulos, Konstantinos, Konstantinos Imprialos, Vasilios Papademetriou, Charles Faselis, Kostas Tsioufis, Kyriakos Dimitriadis y Michael Doumas. "Primary Aldosteronism: Novel Insights". Current Hypertension Reviews 16, n.º 1 (13 de febrero de 2020): 19–23. http://dx.doi.org/10.2174/1573402115666190415155512.

Texto completo
Resumen
Background: Primary aldosteronism is one of the most common causes of secondary hypertension. Patients with this endocrine syndrome are at increased cardiovascular risk, higher than hypertensive individuals with equal blood pressure levels. Objectives: The study aimed to thoroughly present and critically discuss the novel insights into the field of primary aldosteronism, focusing on the clinically meaningful aspects. Method: We meticulously evaluated existing data in the field of primary aldosteronism in order to summarize future perspectives in this narrative review. Results: Novel data suggests that a subclinical form of primary aldosteronism might exist. Interesting findings might simplify the diagnostic procedure of the disease, especially for the localization of primary aldosteronism. The most promising progress has been noted in the field of the molecular basis of the disease, suggesting new potential therapeutic targets. Conclusion: Several significant aspects are at early stages of evaluation. Future research is essential to investigate these well-promising perspectives.
Los estilos APA, Harvard, Vancouver, ISO, etc.
También puede estar interesado en las bibliografías sobre el tema "Aldosteronism" para otros tipos de fuentes:
Tesis
Ofrecemos descuentos en todos los planes premium para autores cuyas obras están incluidas en selecciones literarias temáticas. ¡Contáctenos para obtener un código promocional único!

Pasar a la bibliografía